| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5305 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1672* | 2021 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1331 | 2021 |
| Single-cell multi-omics analysis of the immune response in COVID-19 E Stephenson, G Reynolds, RA Botting, FJ Calero-Nieto, MD Morgan, ... Nature medicine 27 (5), 904-916, 2021 | 514 | 2021 |
| Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis … KF Baker, JD Isaacs Annals of the rheumatic diseases 77 (2), 175-187, 2018 | 384 | 2018 |
| First experience of COVID-19 screening of health-care workers in England E Hunter, DA Price, E Murphy, IS van der Loeff, KF Baker, D Lendrem, ... The Lancet 395 (10234), e77-e78, 2020 | 375 | 2020 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study JJ Manson, C Crooks, M Naja, A Ledlie, B Goulden, T Liddle, E Khan, ... The Lancet Rheumatology 2 (10), e594-e602, 2020 | 268 | 2020 |
| COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience AM Shields, SO Burns, S Savic, AG Richter, A Anantharachagan, ... Journal of Allergy and Clinical Immunology 147 (3), 870-875. e1, 2021 | 226 | 2021 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 153* | 2021 |
| An outbreak of norovirus infection linked to oyster consumption at a UK restaurant, February 2010 K Baker, J Morris, N McCarthy, L Saldana, J Lowther, A Collinson, ... Journal of public health 33 (2), 205-211, 2011 | 87 | 2011 |
| National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysis KF Baker, AT Hanrath, IS van der Loeff, LJ Kay, J Back, CJA Duncan Clinical Medicine 21 (2), 84, 2021 | 76 | 2021 |
| Predicting drug-free remission in rheumatoid arthritis: a prospective interventional cohort study KF Baker, AJ Skelton, DW Lendrem, A Scadeng, B Thompson, AG Pratt, ... Journal of autoimmunity 105, 102298, 2019 | 49 | 2019 |
| COVID-19 Management in a UK NHS Foundation trust with a high consequence infectious diseases centre: a retrospective analysis KF Baker, AT Hanrath, IS van der Loeff, SA Tee, R Capstick, G Marchitelli, ... Medical Sciences 9 (1), 6, 2021 | 42 | 2021 |
| Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK AM Shields, A Anantharachagan, G Arumugakani, K Baker, S Bahal, ... Clinical and experimental immunology 209 (3), 247-258, 2022 | 33 | 2022 |
| Evaluation of procalcitonin-guided antimicrobial stewardship in patients admitted to hospital with COVID-19 pneumonia M Calderon, A Li, JC Bazo-Alvarez, J Dennis, KF Baker, ... JAC-Antimicrobial Resistance 3 (3), dlab133, 2021 | 29 | 2021 |
| Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19 K Stamatelopoulos, G Georgiopoulos, KF Baker, G Tiseo, D Delialis, ... Scientific Reports 11 (1), 20239, 2021 | 23 | 2021 |
| Prospects for therapeutic tolerance in humans KF Baker, JD Isaacs Current opinion in rheumatology 26 (2), 219-227, 2014 | 21 | 2014 |
| “Living a normal life”: a qualitative study of patients’ views of medication withdrawal in rheumatoid arthritis KF Baker, JD Isaacs, B Thompson BMC rheumatology 3, 1-8, 2019 | 20 | 2019 |
| Use of structured musculoskeletal examination routines in undergraduate medical education and postgraduate clinical practice–a UK survey KF Baker, S Jandial, B Thompson, D Walker, K Taylor, HE Foster BMC Medical Education 16, 1-6, 2016 | 19 | 2016 |
